23andMe expands to the UK despite US restrictions

23andMe, the genetics company, is expanding its Personal Genome Service to the UK market. Perhaps wary of the troubles that have plagued the company in the US, 23andMe notes that its services are not diagnostic in its UK press release. That doesn’t stop the company from promising to reveal risk factors and genes for sickle cell anemia, cystic fibrosis, Alzheimer’s disease and Parkinson’s disease — using the same health reports that U.S. officials have suspended.

Continue reading…

The Verge – All Posts

Leave a Comment